Under the co-operative R&D agreement, BN ImmunoTherapeutics has rights to exclusively license intellectual property that results from this collaboration. Bavarian Nordic will in the future explore opportunities for
Johnson & Johnson Development Corporation led the round, joined by Agate Medical Investments, headed by Israel’s former minister of health Danny Naveh. Prominent existing investors who also participated
Under the terms of the agreement, ICU Medical said that it will offer Premier its complete line of Clave and MicroClave needleless IV systems, its valued custom IV
LX7101 is a small molecule compound that may have application in treating glaucoma by lowering fluid pressure in the eye through a new mechanism of action. Lexicon said
C-reactive protein (CRP) levels are frequently elevated in patients with a variety of diseases including cardiovascular disease, Crohn’s disease, rheumatoid arthritis and end-stage renal disease. The Phase I
Under the terms of the agreement, Diakron has the exclusive rights to develop, and, if approved, market and distribute the compound worldwide. In a simultaneous transaction, Orchid Chemicals
Morphotek said that it will apply its proprietary Morphodoma antibody technology to the development of novel human therapeutic antibodies for use in the treatment of prostate cancer. This
The relationship between Tekmira and Bristol-Myers Squibb builds upon earlier work conducted at Bristol-Myers Squibb using small interfering RNA (siRNA) delivery technology provided by privately held Protiva Biotherapeutics.
The intention to make the voluntary takeover offer for a cash consideration of E6.25 per share was announced on July 3, 2008. The offer period will expire on
Hoana Medical said that Kahala Nui joins a list of progressive healthcare facilities by providing the LifeBed patient vigilance system technology that tracks a patient’s or residents’ vital
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.